1. Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo- Controlled Trial 
Dipankar Sircar, MD, DM, Soumya Chatterjee, MD, Rajesh Waikhom, MD, DM, Vishal Golay, MD, DM, Arpita Raychaudhury, MD, DM, Suparna Chatterjee, MD, Rajendra Pandey, MD, DM 
American Journal of Kidney Diseases 
Volume 66, Issue 6, Pages (December 2015)
DOI: /j.ajkd
Copyright © 2015 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1
Flow diagram of single-center trial evaluating febuxostat in comparison to placebo in asymptomatic hyperuricemia in individuals with chronic kidney disease stages 3 to 4.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2015 National Kidney Foundation, Inc. Terms and Conditions